Topical corticosteroid eye drop is the mainstay for preventing and treating corneal graft rejection. While the frequent topical corticosteroid use is associated with risk of intraocular pressure (IOP) elevation and poor patient compliance that leads to graft failure and the requirement for a repeated, high-risk corneal transplantation. Here, we developed dexamethasone sodium phosphate (DSP)–loaded dicarboxyl-terminated poly(lactic acid) nanoparticle (PLA DSP-NP) formulations with relatively high drug loading (8 to 10 weight %) and 6 months of sustained intraocular DSP delivery in rats with a single dosing. PLA DSP-NP successfully reversed early signs of corneal rejection, leading to rat corneal graft survival for at least 6 months. Efficacious PLA DSP-NP doses did not affect IOP and showed no signs of ocular toxicity in rats for up to 6 months. Subconjunctival injection of DSP-NP is a promising approach for safely preventing and treating corneal graft rejection with the potential for improved patient adherence.
24 April 2020 in Graefe's Archive for Clinical and Experimental Ophthalmology
A 40-year-old man had uneventful small-incision lenticule extraction. Three days later, the uncorrected distance visual acuity was 20/20 and the cornea was clear without intraocular inflammatory in both eyes. At 6 days, the patient presented with a foreign-body sensation in the right eye but with no decrease in vision. Dense infiltration was visible at the inferior nasal corneal rim on slitlamp microscopy. Anterior segment optical coherence tomography showed the lesion in the junction of the capsular bag and the lenticular edge. Confocal microscopy showed a large number of inflammatory cells and dendritic cells in the infiltration area. After the patient's frequent use of antibiotic and glucocorticoid eyedrops, the inferior corneal infiltration was absorbed and there were significantly fewer inflammatory cells and dendritic cells.
18 May 2024 in Graefe's Archive for Clinical and Experimental Ophthalmology